Education
About Us
Working with TipRanks
Follow Us
P. Kent Hawryluk Insider Profile
11 Followers
P. Kent Hawryluk, Director at MetaVia, holds 1.22M shares in MBX Biosciences, Inc. (Ticker: MBX), holds 32.06K shares in MetaVia (Ticker: MTVA). Most recently, P. Kent Hawryluk Bought ― shares of MBX Biosciences, Inc. on Mar 16, 2026 for an estimated value of $525.59K.
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+94.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that P. Kent Hawryluk holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 05, 2025 - Feb 05, 2026
Return:+220.40%
The most profitable trade made by P. Kent Hawryluk
P. Kent Hawryluk's Trading History
MetaVia
Mar 14, 2017
Director
Informative Buy
236.75K
$47.45K
MBX Biosciences, Inc.
Mar 16, 2026
President & CEO, Director
Informative Buy
525.59K
$34.54M
List of latest transactions for each holding click on a transaction to see P. Kent Hawryluk's performance on stock
You May Also Like
P. Kent Hawryluk insider profile FAQ
What is the percentage of profitable transactions made by P. Kent Hawryluk?
The percentage of profitable transactions made by P. Kent Hawryluk is 67%.
What is the average return per transaction made by P. Kent Hawryluk?
The average return per transaction made by P. Kent Hawryluk is 94.10%.
What stocks does P. Kent Hawryluk hold?
P. Kent Hawryluk holds: MTVA, MBX stocks.
What was P. Kent Hawryluk’s latest transaction?
P. Kent Hawryluk latest transaction was an Informative Buy of $525.59K.
What was P. Kent Hawryluk's most profitable transaction?
P. Kent Hawryluk’s most profitable transaction was an Informative Buy of MBX stock on February 5, 2025. The return on the trade was 220.40%.
What is P. Kent Hawryluk's role in MetaVia?
P. Kent Hawryluk's role in MetaVia is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.